Where is the hpv vaccination point in the home of Shenyang Hunnan District CDC? Have an address and a phone number.

Where is the hpv vaccination point in the home of Shenyang Hunnan District CDC

Where is the hpv vaccination point in the home of Shenyang Hunnan District CDC? Have an address and a phone number.

Where is the hpv vaccination point in the home of Shenyang Hunnan District CDC?

Address and telephone number of family hpv vaccination point in Shenyang Hunnan District CDC:

Address: No.2 Gate, No.29-8 Shen Ying Road, Hunnan District, Shenyang 1 (50 meters north of the west gate of Kangtai Community)

Tel: 024-3 1835303

Business hours: 8:00- 19:00, weekends and legal holidays.

? The difference between bivalent, tetravalent and nine-valent HPV vaccines;

At present, there are three kinds of human papillomavirus vaccines listed in the world: bivalent, tetravalent and nonavalent, and "valence" represents the type of virus that the vaccine can prevent.

The bivalent vaccine can prevent HPV 16 and HPV 18 virus infection. International research data show that more than 70% of cervical cancer is caused by these two viruses.

The tetravalent vaccine can prevent the infection of HPV types 6, 1 1, 16 and 18. Although HPV6 and HPV 1 1 are not high-risk HPV viruses for cervical cancer, they can cause vulvar condyloma acuminatum, and these two vaccines have been listed at home and abroad.

Bivalent and tetravalent are used for women aged 9 to 45. Vaccines are usually injected in three times and last for ***6 months before they are effective. Vaccinate bivalent vaccine at 0, 1 and 6 months; Vaccinate with tetravalent vaccine at 0, 2 and 6 months.

The nine-valent vaccine targets nine subtypes of HPV6, 1 1, 16,18,31,33,45,52,58. International research data show that the nine-valent vaccine can prevent 90% of cervical cancer.

The nine-valent HPV vaccine approved in China is a virus-like particle composed of major capsid proteins of human papillomavirus types 6, 1 1 6, 18, 3 1, 33, 45, 52 and 58. The vaccine is suitable for women aged 16 to 26, and can be used to prevent cervical cancer, vulvar cancer, vaginal cancer, anal cancer's disease, genital warts, persistent infection, precancerous lesions or atypical lesions caused by human papillomavirus.

At present, bivalent and tetravalent vaccines listed in China can prevent and control the risk of cervical cancer by 70%, and the nine-valent vaccine can prevent cervical cancer by 90%. The public can choose to be vaccinated with different titer types of human papillomavirus vaccine according to their age and economic situation.

& gt& gt& gt